Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Current sp

There are still 5 months to the year end and I expect licensing to grow much faster since the Marshall settlement and the additional 6 licenses since December 3.

As TPL have "met with 81 companies", I would expect at least 20 more to license by year end, all now paying higher fees. It is for this reason that I still maintain my belief of an eps of not less than $1.00 for the year. Remember, "Over 300 of those companies have revenues exceeding $1 billion per year, and over 220 of the companies put on notice have responded"

http://www.ptsc.com/news/press_releases/2007notes.asp

Turley will have been kept updated as to licensing progress: numbers in advanced discussion; likely time frame; and approximate fees being negotiated, and for this reason I can see no reason why he can't give a full year earnings guidance with the upcoming 10Q.

Please try the math for yourself and see what eps you calculate with the above variables.

 

 

 

Be well

Share
New Message
Please login to post a reply